Mesothelioma Solicitors - Asbestos Compensation Claim Lawyers



Mesothelioma is a type of cancer of the pleura (tissue surrounding the lungs), or of the peritoneum (lining of the abdomen). It is usually caused by exposure to asbestos. In fact, there is a history of occupational asbestos exposure in up to 90% of mesothelioma cases.

Mean latent interval between first exposure to asbestos and death from mesothelioma is around 40 years. It is rare to find a case where the latency period is less than 10 years. Whilst all types of asbestos can cause mesothelioma, amphibole asbestos is the most potent.

If you have been diagnosed with mesothelioma, you should seek legal advice from an expert lawyer. Our lawyers have many years experience in handling mesothelioma compensation claims, including those involving the mining industry.

Call our helpline, complete the Contact Form or send an email to speak to a meothelioma solicitor about No Win No Fee miners compensation claims.

Mesothelioma Symptoms

The early symptoms of miners mesothelioma are generally non-specific, and may lead to a delay in diagnosis. As the disease progresses the person may feel some or all of the following symptoms:

  • Chest pain
  • Breathlessness
  • Profuse sweating
  • Weight loss
  • Dry cough
  • Fever

Symptoms of peritoneal mesothelioma may include pain or swelling in the abdomen due to a build-up of fluid, weight loss, bowel obstruction, nausea, anaemia, swollen feet.


MRI - This technique is superior to a CT scan in determining the extent of a malignant mesothelioma particularly when the tumour invades local structures such as the ribs and the diaphragm.

Biopsy - ultrasound or CT-guided cutting needle biopsy and thoracoscopic biopsy of pleural masses have a high diagnostic yield and should be used in preference to blind biopsy techniques.

A chest x-ray and CT scan should be ordered. These will typically feature:

  • Moderate to large pleural effusion (accumulation of fluid);
  • Pleural mass or thickening without fluid;
  • Entrapment of lung resulting in small hemithorax;
  • Local invasion of chest wall, ribs, heart, mediastinum, and diaphragm, transdiaphragmatic spread and invasion of contralateral pleura.


Management of pleural effusions. Pleural effusion caused by heart failure or infection can usually be resolved by directing treatment at the cause, however, when testing has realised no diagnosis, and fluid continues to build or recur, doctors may recommend chest tube drainage and chemical pleurodesis or 'talc pleurodesis.'

Prophylactic Radiotherapy greatly reduces chest wall invasion by tumour following pleural aspiration or biopsy. Palliative radiotherapy provides pain relief in some patients.

Surgery consists of cutting open a patient and removing the majority of cancerous cells from either the lining of the lungs, abdomen or heart.

Chemotherapy is often used in conjunction with other treatment types such as radiation therapy or surgery. There are a number of mesothelioma chemotherapy drugs being used, however, none have been able to provide a successful treatment for malignant mesothelioma.

Early involvement of a pain relief and palliative care service is required.


Median survival for persons with mesothelioma is poor, varying 8 to 14 months in different studies. Prognosis is better with the epithelial type when compared with the fibrous type mesothelioma.